Regeneron Pharmaceuticals Non-GAAP EPS of $10.09 beats by $0.53, revenue of $3.16B
Regeneron Pharmaceuticals press release  (REGN): Q1  Non-GAAP EPS of $10.09  beats by $0.53. Revenue of $3.16B (+6.4% Y/Y)  beats by $160M. First quarter 2023 Dupixent global...
Below is an instruction that describes a task. Write a response that appropriately completes the request.

### Instruction: Regeneron Pharmaceuticals Non-GAAP EPS of $10.09 beats by $0.53, revenue of $3.16B

### Response: Regeneron Pharmaceuticals press release  (REGN): Q1  Non-GAAP EPS of $10.09  beats by $0.53. Revenue of $3.16B (+6.4% Y/Y)  beats by $160M. First quarter 2023 Dupixent global...